Webinar
Potency testing of anti-cancer immune cells – easy, quantitative, in real time

Immuno-Oncology therapies mobilize the human immune system to fight against tumor cells. Since the first immuno-oncology treatment was approved in 2010, this type of therapy has proven it´s great potential in cancer therapies worldwide. Visit our webinar to explore how to easily unravel the effectiveness of stimulated lymphocytes, monoclonal antibodies or checkpoint inhibitors by using xCELLigence Real Time Cell Analyzer. Without any cell labelling, xCELLigence RTCA systems allow the detection of target cell proliferation and killing in a highly sensitive, quantitative manner. Automated real-time measurements at low or high-throughput level result in highly consistent, user-independent results.